DossierENTITY

Zev Wainberg

Coverage of Zev Wainberg in the Nexus archive.

Earliest in view: May 31 · 12:53 UTCMost recent: May 31 · 12:53 UTC

Co-mentioned in this coverage

daraxonrasibtopic1 pancreatic cancertopic1 Rachna Shroffperson1 University of California, Los Angelesorganization1 University of Arizona Cancer Centerorganization1 Dana-Farber Cancer Instituteorganization1 Revolution Medicinesorganization1 Food and Drug Administrationorganization1 New England Journal of Medicineorganization1

Recent coverage

HEALTHMay 31 · 12:53 UTCAP NEWS
Experimental pill promises new hope for deadly pancreatic cancer
A new experimental pill, daraxonrasib, nearly doubled survival time for patients with advanced pancreatic cancer compared to chemotherapy in a clinical trial. The drug targets a mutated protein present in over 90% of pancreatic cancer cases and showed fewer severe side effects, with patients reporting better quality of life.